(Bloomberg) -- Health-care investment banker Mark Filenbaum is returning to Credit Suisse Group AG after nearly four years at Centerview Partners.
Filenbaum will start with Credit Suisse in New York in November, focusing on health-care services investment banking, according to a memo to staff seen by Bloomberg News.
He’ll report to David Kostel, who became sole global head of the health-care investment banking group in August after Rob Santangelo was appointed co-head of global energy and infrastructure as well as chair of ESG Advisory.
A spokesman confirmed the contents of the memo.
Filenbaum worked in Credit Suisse’s health-care group for four years before joining Centerview, where he covered health-care services. He’s advised companies including Versant Health, PPD Inc., Anthem Inc. as well as private equity firms like Carlyle Group Inc. and Advent International.
“Mark is an experienced banker with strong industry content, deep client relationships and a collaborative approach that will make him a great fit with our health-care franchise,” Kostel said in the memo.
Credit Suisse’s health-care group has advised on deals this year including Iora Health Inc.’s sale to 1Life Healthcare’s One Medical, Aveanna Healthcare Holdings Inc.’s IPO and 23andMe Holding Co.’s merger with a SPAC.
©2021 Bloomberg L.P.